Light Mode
$1.75 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.75, $0.08 below the day’s high of $1.83
+1.19 (+214.18%) / 6M
Momentum, market sentiment, and recent alerts
CALC reads very good: price sits above one of the two key moving averages, the 12-month move is -41.1%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
CalciMedica, Inc. is a clinical-stage biopharmaceutical company, which engages in developing therapies for life-threatening inflammatory diseases. The firm's product candidate, Auxora, helps in treating acute pancreatitis and asparaginase-associated pancreatitis. The company was founded by Kenneth A. Stauderman and Gonul Velicelebi in 2007 and is headquartered in La Jolla, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.